Saponin Based Adjuvants

Quillaja saponin-based adjuvants including QS-21 are highly effective adjuvants for enhancing immune response to vaccine antigens and is a vital component enabling new vaccine candidates and advancing vaccine development.   However, saponins are currently supplied from non-sustainable sources creating potential supply chain risks and limiting their potential in new vaccine developments. We’re working to deliver a solution.

TECHNOLOGY PARTNERSHIP

SPI Pharma, Inc. and Q-Vant Bioscences have agreed to come together to leverage Q-Vant’s leadership in unique, sustainable saponin extraction technology with SPI’s global reach in the pharmaceutical industry and SPI’s strict quality/GMP standards. We will work together to expand commercial-scale GMP manufacturing of high-purity saponins and enable global pharma customers access to sustainable, scalable, and fully-integrated supply of saponin adjuvants.

READ THE PRESS RELEASE

SUSTAINABLE DELIVERY OF BILLIONS OF DOSES OF SAPONIN-BASED ADJUVANTS

Q-VANT has solved the supply chain problem of QS 21 and other Quillaja based saponin adjuvants for the global pharmaceutical market.

  • World class knowledge and experience in quillaja saponin supply chain, agronomy, extraction and purification. 
  • Disruptive technology to increase the potential for sustainable QS 21
  • First company that is vertically integrated including a secured sustainable quillaja raw material supply through pharma cGMP commercial scale production of QS 21 and other saponin based adjuvants.

WWW.Q-VANT.COM

SPI Pharma has extensive experience and knowledge of aluminum hydroxide chemistry, with more than 20 years for Alum gels as a vaccine adjuvant. SPI has served the industry for decades, supplying major vaccine producers.  This reach will allow the market to gain fuller access to Q-Vant’s innovations.

Related Applications

Vaccine Adjuvants

SPI Pharma supplies aluminum hydroxide vaccine adjuvants to enhance and help the ability of your antigen to stimulate the immune system.

Related Products

Q- VET S™ is a Standardized full spectrum saponin product equivalent to Quil A extracted from any part of Quillaja saponaria Molina and purified using our proprietary technology. This guarantees a fully sustainable supply chain, and long term continuity of supply (Download the brochure).

QS-21 INFINITY™ is Q-Vant’s pure QS 21 fraction collected from a fully sustainable raw material source for pre clinical and clinical use. The product is made under pharma GMP (Download the brochure)

Contact our Experts Today

Learn how SPI Pharma and Q-Vant can enhance access to Saponin based Adjuvants and enhance your vaccine development.  Contact us to discuss your developments with our experts